Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from Eli Lilly
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from Eli Lilly
10 March 2011 (22.31 Kb 6 sec) |
This page was last updated: 08 March 2011